Zurich Cantonal Bank
KYMR icon

Zurich Cantonal Bank’s Kymera Therapeutics KYMR Stock Holding History

Zurich Cantonal Bank’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.85M Buy
33,591
+1,530
+5% +$131K 0.01% 798
2026
Q1 		$2.67M Buy
+32,061
New +$2.54M 0.01% 887
2025
Q4 		– Sell
-14,842
Closed -$1M – 3066
2025
Q3 		$840K Buy
14,842
+1,583
+12% +$71.4K ﹤0.01% 1392
2025
Q2 		$579K Buy
13,259
+1,911
+17% +$65.8K ﹤0.01% 1570
2025
Q1 		$311K Sell
11,348
-606
-5% -$22.1K ﹤0.01% 1874
2024
Q4 		$481K Buy
11,954
+665
+6% +$30K ﹤0.01% 1655
2024
Q3 		$534K Buy
11,289
+915
+9% +$40.4K ﹤0.01% 1520
2024
Q2 		$310K Sell
10,374
-1
-0% -$35 ﹤0.01% 1810
2024
Q1 		$417K Buy
10,375
+4,335
+72% +$155K ﹤0.01% 1596
2023
Q4 		$154K Hold
6,040
– – ﹤0.01% 2232
2023
Q3 		$84K Hold
6,040
– – ﹤0.01% 2431
2023
Q2 		$139K Hold
6,040
– – ﹤0.01% 2153
2023
Q1 		$179K Buy
6,040
+1,055
+21% +$34K ﹤0.01% 1944
2022
Q4 		$124K Buy
4,985
+1,225
+33% +$32.7K ﹤0.01% 2138
2022
Q3 		$82K Hold
3,760
– – ﹤0.01% 2369
2022
Q2 		$74K Hold
3,760
– – ﹤0.01% 2431
2022
Q1 		$159K Buy
3,760
+488
+15% +$20.6K ﹤0.01% 2037
2021
Q4 		$208K Buy
3,272
+1,467
+81% +$85.4K ﹤0.01% 2042
2021
Q3 		$106K Buy
+1,805
New +$105K ﹤0.01% 2307

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Zurich Cantonal Bank's KYMR Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Kymera Therapeutics (KYMR) stake by 4.8% in Q2 2026, buying an estimated $131K and bringing the position to 33,591 shares worth $3.85M. The position accounts for 0.01% of the portfolio, ranked #798.

Zurich Cantonal Bank first reported a position in KYMR in Q3 2021 and has held it in 19 quarters since. 275 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Zurich Cantonal Bank held 33,591 shares of Kymera Therapeutics worth $3.85M as of Q2 2026.
  • Zurich Cantonal Bank bought 1,530 Kymera Therapeutics shares in Q2 2026, an estimated $131K.
  • Kymera Therapeutics made up 0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #798 holding.
  • Zurich Cantonal Bank first reported a position in Kymera Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • 275 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.